December 9, 2020
HALIX inks deal with AstraZeneca for commercial manufacture of COVID-19 vaccine
HALIX B.V. has signed an agreement with AstraZeneca AB for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine.